NEW YORK (AP) — NEW YORK (AP) — Axsome Therapeutics Inc. (AXSM) on Monday reported a loss of $12.9 million in its third quarter.

On a per-share basis, the New York-based company said it had a loss of 25 cents.

The results beat Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of 69 cents per share.

The biopharmaceutical company posted revenue of $259.7 million in the period, also topping Street forecasts. Seven analysts surveyed by Zacks expected $246.4 million.

Axsome shares have fallen 21% since the beginning of the year. The stock has increased 7% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AXSM at https://www.zacks.com/ap/AXSM